Efficacy Study of Lucentis in the Treatment of Retinoblastoma

NCT01899066 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Retinoblastoma

Interventions

DRUG: Lucentis, chemotherapy
DRUG: chemotherapy

Sponsor

Sun Yat-sen University